Condition
Appendiceal Cancer clinical trials and research
As of November 12, 2026, Find a Trial lists 7 Appendiceal Cancer clinical trials that are recruiting, at sites in 2 countries (most in United States (6), United Kingdom (1)). By phase: Phase 1 (1), Phase 4 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 7Clinical trials
- 2Countries
Newest Appendiceal Cancer clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Molecular profiling to improve risk stratification in appendiceal cancer | — | Durate, California | Recruiting | May 14, 2026 |
| Mass-based drug screening to guide personalized HIPEC for high-grade appendiceal and colorectal cancer with peritoneal spread. | — | New Haven, Connecticut | Recruiting | Dec 18, 2025 |
| Intraoperative imaging of gastrointestinal cancers using pafolacianine (CYTALUX™) | Phase 4 | Los Angeles, California | Recruiting | Aug 15, 2025 |
| Combining local therapy with ongoing systemic treatment for certain cancers | — | Sacramento, California | Recruiting | Oct 26, 2023 |
| Investigating the genetics of appendix cancer | — | Nashville, Tennessee | Recruiting | Feb 21, 2023 |
| Analyzing genetic mutations in appendiceal cancer | — | Manchester | Recruiting | May 6, 2022 |
| Personalized chemotherapy for abdominal cancer treatment | Phase 1 | Bethesda, Maryland | Recruiting | Apr 15, 2021 |
All recruiting trials (7)
-
Molecular profiling to improve risk stratification in appendiceal cancer
Researchers test DNA methylation and m6A epitranscriptomic features in archived appendiceal cancer tissue to see if molecular subtypes and risk scores can better predict outcomes.
-
Mass-based drug screening to guide personalized HIPEC for high-grade appendiceal and colorectal cancer with peritoneal spread.
This tests whether a lab-based mass response test on tumor biopsies can pick the best chemotherapy to use during repeated HIPEC for people with unresectable peritoneal metastases from high-grade appendiceal or colorectal cancer.
-
Intraoperative imaging of gastrointestinal cancers using pafolacianine (CYTALUX™)
This trial will test whether an injection of CYTALUX™ (pafolacianine) with near-infrared imaging helps surgeons find gastric, esophageal, or appendiceal adenocarcinomas during surgery in adults.
-
Combining local therapy with ongoing systemic treatment for certain cancers
This study is testing whether adding local treatments to ongoing systemic therapy can help people with certain cancers keep their disease under control for longer.
-
Investigating the genetics of appendix cancer
This study is trying to find out how genetics might play a role in appendix cancer by following adults with the disease for up to six years.
-
Analyzing genetic mutations in appendiceal cancer
This study looks at the genetic changes in appendiceal cancer to see how they might affect treatment and survival for patients whose cancer has spread.
-
Personalized chemotherapy for abdominal cancer treatment
This study is testing a new way to personalize chemotherapy for patients with abdominal cancer by trying different treatments on their tumor samples before using them during surgery.
Related topics
Quick answers
How many Appendiceal Cancer clinical trials are recruiting right now?
7, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in United States (6 trials), United Kingdom (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 1, Phase 4: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.